As in previous years, growing interest and a better understanding of the complexities of
pulmonary vascular diseases continue to evolve at a healthy pace. The breadth of …

Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic state that can be
found in multiple conditions with associated symptoms of dyspnea, decreased exercise …

Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a
chronic and progressive disorder characterised by angioproliferative vasculopathy in the …

Pulmonary arterial hypertension (PAH) is a vascular remodeling disease with a relentless
course toward heart failure and early death. Existing PAH therapies, all of which were …

Pulmonary arterial hypertension (PAH) is a rare disease, but one that continues to cause
significant morbidity and mortality despite much recent therapeutic progress. PAH is one …

Pulmonary hypertension (PH) is a rare heterogenous disease characterized by elevated
blood pressure in the lungs. Patients with PH require careful evaluation and management at …

Pulmonary hypertension (PH) and its subset, pulmonary arterial hypertension (PAH), are
rare diseases with a significant unmet need. Between the 1980s and 2010s, the 5-year …

Pulmonary hypertension (PH) is recognized as a pathophysiological disorder encompassing
a wide spectrum of clinical conditions related to various cardiovascular and respiratory …

Abstract In February 2018, the 6th World Symposium on Pulmonary Hypertension (WSPH)
brought together experts from various disciplines to review the most relevant clinical and …

High pressure in the lungs, or pulmonary hypertension, is most commonly due to smoking-
related lung disease and conditions affecting the left heart, for example, high blood pressure …